Cost of revenue · 2017–2025
Alnylam Pharmaceuticals cost of revenue
$677M+120.9% · FY2025
Alnylam Pharmaceuticals (ALNY) reported $677M in cost of revenue for fiscal 2025, +120.9% year on year.
| Fiscal year | Cost of revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $677M | +120.9% | Open → |
| FY20242024-12-31 | $307M | +14.3% | Open → |
| FY20232023-12-31 | $268M | +91.3% | Open → |
| FY20222022-12-31 | $140M | +21.9% | Open → |
| FY20212021-12-31 | $115M | +55.0% | Open → |
| FY20202020-12-31 | $74.2M | +196.0% | Open → |
| FY20192019-12-31 | $25.1M | +1,290.8% | Open → |
| FY20182018-12-31 | $1.8M | +$1.8M | Open → |
| FY20172017-12-31 | $0 | — | Open → |
Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Cost of revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Alnylam Pharmaceuticals cost of revenue |url=https://companiesranked.com/en/company/alnylam-pharmaceuticals/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Alnylam Pharmaceuticals cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/alnylam-pharmaceuticals/cost-of-revenueBibTeX
@misc{companiesranked-en-company-alnylam-pharmaceuticals-cost-of-revenue-2026,
author = {{CompaniesRanked}},
title = {{Alnylam Pharmaceuticals cost of revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/alnylam-pharmaceuticals/cost-of-revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-007497 · February 12, 2026
{{cite web |title=Alnylam Pharmaceuticals cost of revenue — 10-K (0001628280-26-007497) |url=https://www.sec.gov/Archives/edgar/data/1178670/000162828026007497/alny-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-12}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.